Although the use of colistin is considered to be effective, other antibiotics are often used in combination with colistin. Many studies have shown good outcomes for patients treated with colistin ...

Analysis of data from 537 US hospitals found that ceftolozane-tazobactam and ceftazidime-avibactam are the most frequently ...

Review of data from the trial found that the vaccine was not sufficiently effective at preventing invasive E coli disease ...

The study addresses the growing threat of multi-drug-resistant (MDR) pathogens, focusing on the efficacy of colistin (COL), a last-resort antibiotic, and its enhanced activity when combined with ...

The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.

Department of Pharmacology and Toxicology, College of Veterinary Medicine, Henan Agricultural University, China; ...

AbbVie announced that the US FDA has approved aztreonam and avibactam (Emblaveo), in combination with metronidazole, for ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

A new ally is emerging in the increasingly urgent battle against superbugs – and you might have encountered it before at the dinner table. New research reveals that proteins in Sydney rock oyster ...

Emblaveo marks the first and only fixed-dose intravenous monobactam/β-lactamase inhibitor combination antibiotic to be ...